Microsaic Systems plc Trading Update (7308Q)
30 6월 2022 - 3:00PM
UK Regulatory
TIDMMSYS
RNS Number : 7308Q
Microsaic Systems plc
30 June 2022
30 June 2022
Microsaic Systems plc
("Microsaic" or the "Company")
Trading Update
H1 2022 revenues up 40% due to new services division
Strong H2 2022 order book for services continues to grow
Microsaic Systems plc (AIM: MSYS), is pleased to announce an
unaudited trading update for the six months ended 30 June 2022 ("H1
2022"). The launch of the Microsaic Services Division, earlier this
year, has resulted in an uplift of 40% in revenues to GBP701k in H1
2022 (H1 2021: GBP499k) and a healthy order book for H2. The
provision of these services only commenced in April and include
R&D Engineering Consultancy, Analytical and AI Software Service
Programmes designed for the medical device, environmental,
aerospace and food industries.
The Company's website has also been updated to highlight the
additional services being offered by the Microsaic team.
Gerry Brandon, Acting Executive Chairman of Microsaic Systems
plc, commented
" Microsaic's new high-tech services division has quickly
generated revenues and has helped transition the Company from
product sales to customer-centric service solutions in Human and
Environmental Health so far. We are exploring opportunities and
already identified multiple sources of revenues including strategic
partners and OEM agreements, we have a healthy order book for H2
2022 which is the strongest ever going in to the second half ."
Enquiries:
Microsaic Systems plc +44 (0) 734 0055 648
Gerry Brandon, Executive Chairman
N+1 Singer (Nominated Adviser & Joint
Broker) +44 (0)20 7496 3000
Aubrey Powell / George Tzimas (Corporate
Finance)
Tom Salvesen (Corporate Broking)
Turner Pope Investments (TPI) Limited
(Joint Broker)
Andy Thacker / James Pope +44 (0) 20 3657 0050
Market Abuse Regulation (MAR) Disclosure
This announcement contains inside information as stipulated
under the UK version of the market abuse regulation no 596/2014
which is part of English law by virtue of the European (withdrawal)
act 2018, as amended. On publication of this announcement via a
regulatory information service, this information is considered to
be in the public domain.
About Microsaic Systems
Microsaic floated on AIM in 2011 to develop and commercialise
micro-engineering chip-based mass spectrometry equipment. Having
invested c. GBP30m over 20 years of development, Microsaic has a
robust and innovative patent portfolio in cutting-edge technology
designed and developed for "Industry 4.0" application. Microsaic
serves markets in Human Health, Environmental Health and
Diversified Industries. Microsaic's system solutions enable
analytical detection and characterisation at the point-of-need,
whether within a conventional laboratory setting, or within a
bioprocessing facility for continuous MS detection data at multiple
steps in the process workflow.
Microsaic's products and systems are commercially available
through global markets via a network of regional and local
partners, targeting its core laboratory, manufacturing and point of
need applications .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
TSTBKCBDBBKBOAB
(END) Dow Jones Newswires
June 30, 2022 02:00 ET (06:00 GMT)
Metir (AQSE:MSYS.GB)
과거 데이터 주식 차트
부터 3월(3) 2025 으로 4월(4) 2025
Metir (AQSE:MSYS.GB)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 4월(4) 2025